logo

Regeneron Pharmaceuticals (REGN)



Trade REGN now with
  Date
  Headline
11/12/2018 7:11:21 AM Ziopharm Announces Immuno-oncology Deal With Regeneron To Evaluate Combination Therapy For Patients With Brain Cancer
11/7/2018 5:08:11 PM Sanofi: NEJM Publish Positive Detailed Results Of The 18,924-patient ODYSSEY OUTCOMES Trial
11/6/2018 6:35:48 AM Regeneron Pharmaceuticals Q3 EPS $5.17 Vs $3.32 Last Year
10/25/2018 7:08:44 AM Regeneron Says Phase 3 PANORAMA Trial Of EYLEA Injection Meets Primary Endpoint And Key Secondary Endpoints
10/22/2018 7:02:47 AM Regeneron: FDA Approves Asthma Indication For Dupixent
10/19/2018 7:05:03 AM Regeneron Pharma And Sanofi To Present Kevzara Data From Phase 3 Clinical Program At 2018 ACR/ARHP Annual Meeting
10/16/2018 1:01:56 AM Regeneron: Dupixent Show Positive Topline Results In 2 Phase 3 Trials For Chronic Rhinosinusitis With Nasal Polyps
10/15/2018 8:05:22 AM Aimmune Reports Initiation Of Phase 2 Study With Regeneron, Sanofi Of AR101 With Adjunctive Dupilumab In Peanut-Allergic
9/13/2018 7:02:26 AM Regeneron: FDA To Review EYLEA Injection For Treatment Of Diabetic Retinopathy